These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22180252)

  • 21. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.
    Patti G; Pelliccia F; Gaudio C; Greco C
    Am J Cardiol; 2015 Mar; 115(6):837-43. PubMed ID: 25620037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL;
    N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.
    Agarwal S; Bajaj NS; Kumbhani DJ; Tuzcu EM; Kapadia SR
    JACC Cardiovasc Interv; 2012 Jul; 5(7):777-89. PubMed ID: 22814784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials.
    Garg A; Thawabi M; Rout A; Sossou C; Cohen M; Kostis JB
    Cardiology; 2019; 144(1-2):40-49. PubMed ID: 31574522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent foramen ovale closure for patients with cryptogenic stroke: A systematic review and comprehensive meta-analysis of 5 randomized controlled trials and 14 observational studies.
    Chen X; Chen SD; Dong Y; Dong Q
    CNS Neurosci Ther; 2018 Oct; 24(10):853-862. PubMed ID: 29804325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
    Sitwala P; Khalid MF; Khattak F; Bagai J; Bhogal S; Ladia V; Mukherjee D; Daggubati R; Paul TK
    Cardiovasc Revasc Med; 2019 Aug; 20(8):687-694. PubMed ID: 30282597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials.
    Wang TKM; Wang MTM; Ruygrok P
    Heart Lung Circ; 2019 Apr; 28(4):623-631. PubMed ID: 29602754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
    Schuchlenz HW; Weihs W; Berghold A; Lechner A; Schmidt R
    Int J Cardiol; 2005 May; 101(1):77-82. PubMed ID: 15860387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S; Russo F; Campana C; Agostoni E
    Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis.
    Vukadinović D; Schirmer SH; Vukadinović AN; Ukena C; Scheller B; Mahfoud F; Böhm M
    Clin Res Cardiol; 2019 Feb; 108(2):157-166. PubMed ID: 30051178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.
    Ntaios G; Papavasileiou V; Sagris D; Makaritsis K; Vemmos K; Steiner T; Michel P
    Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Cryptogenic Stroke.
    Ando T; Holmes AA; Pahuja M; Javed A; Briasoulis A; Telila T; Takagi H; Schreiber T; Afonso L; Grines CL; Bangalore S
    Am J Cardiol; 2018 Mar; 121(5):649-655. PubMed ID: 29306484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
    Søndergaard L; Kasner SE; Rhodes JF; Andersen G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjöstrand C; Roine RO; Hildick-Smith D; Spence JD; Thomassen L;
    N Engl J Med; 2017 Sep; 377(11):1033-1042. PubMed ID: 28902580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
    Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated systematic review and meta-analysis.
    Goel S; Patel S; Zakin E; Pasam RT; Gotesman J; Malik BA; Ayzenberg S; Frankel R; Shani J
    Indian Heart J; 2019; 71(6):446-453. PubMed ID: 32248916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Patent Foramen Ovale Closure More Effective Than Medical Therapy in Preventing Stroke Recurrence in Patients With Cryptogenic Stroke?: A Critically Appraised Topic.
    Valencia-Sanchez C; Fortuin FD; Sweeney JP; Ingall TJ; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2018 Sep; 23(5):175-180. PubMed ID: 30169372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.
    Udell JA; Opotowsky AR; Khairy P; Silversides CK; Gladstone DJ; O'Gara PT; Landzberg MJ
    Can J Cardiol; 2014 Oct; 30(10):1216-24. PubMed ID: 25154803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    Nasir UB; Qureshi WT; Jogu H; Wolfe E; Dutta A; Majeed CN; Tan WA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):187-193. PubMed ID: 30905408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.